Press releases

articles from December 2017

Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $110 million (£85 million) Series B financing

Read more

Orchard Therapeutics and Généthon Announce Gene Therapy alliance in X-linked Chronic Granulomatous Disease

Orchard Therapeutics announces today a strategic alliance with Généthon, to develop gene therapy for X-linked chronic granulomatous disease (“X-CGD”)

Read more